Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-04

Clinical Trial Update: Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects [Phase 3]

View source ↗

Summary

Open-label extension of a Phase 3 randomized trial evaluating Lovaza (omega-3-acid ethyl esters) in combination with simvastatin for hypertriglyceridemia; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOVAZA (OMEGA-3-ACID ETHYL ESTERS)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED | Results posted: 2009-08-04